Jeff Goad, PharmD, MPH, APH

Pharmacists adapt to new CDC guidelines, emphasizing pneumococcal vaccination for adults 50+, enhancing patient screening and vaccination efficiency.

Explore how pneumococcal vaccine efficacy is measured, its real-world impact, and the importance of immunobridging for informed vaccination decisions.

Jeffery Goad, PharmD, MPH, outlines how recent changes to the childhood immunization schedule may affect vaccine confidence, uptake, and public health, while highlighting the essential role pharmacists play in patient education.

Jeffery A. Goad, PharmD, MPH, stresses that consistent, evidence-based communication from pharmacists and other health care professionals is essential to maintaining public trust and preventing declines in childhood vaccination.

Jeffery A. Goad, PharmD, MPH, explains how the shift toward shared clinical decision-making for pediatric vaccines may complicate counseling, reduce vaccine uptake, and increase public health risks.

Jeffery A. Goad, PharmD, MPH, explains how recent HHS policy changes reorganizing the childhood immunization schedule could complicate routine vaccination practices and increase the risk of gaps in pediatric disease prevention.

The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.

Medical experts highlight the importance of clinical decision-making and the pivotal role pharmacies play in initiating conversations and identifying high-risk patients during consultations for new medications.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

Influenza viruses typically circulate in the Northern Hemisphere during the winter and spring, but they occasionally can circulate more during the summer months, as did the 2009 H1N1 pandemic strain.

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.

Drs Angela Rasmussen and Donald Alcendor detail the roadblocks facing COVID-19 booster shots.

Donald Alcendor, PhD, and Angela Rasmussen, PhD, explain how to discuss the importance of COVID-19 booster shots with patients.

Jeff Goad, PharmD, MPH, and Angela Rasmussen, PhD review the population trends of COVID-19 booster shots.

An explanation of the risks associated with COVID-19 booster shots.

Dr Peter Salgo leads a discussion on the safety and efficacy of COVID-19 booster shots with a comparison to historical vaccine rollouts.

A panel of doctors explains whether or not someone can get a different COVID-19 booster from their original vaccinations and how they compare.

Experts discuss who is eligible for COVID-19 booster shots and the misinformation around COVID-19 vaccinations.

Angela Rasmussen, PhD, and Donald Alcendor, PhD have a conversation on the recent expansion of COVID-19 booster shot usage in eligible populations.

Key opinion leaders debate on the necessity of COVID-19 booster shots.

Dr Jason Gallagher explains how COVID-19 booster shots affect herd immunity in the United States.

A panel of experts gives an overview on the purpose of COVID-19 booster shots and their critical importance to population health.

As a whole, adult vaccination coverage has remained unchanged without significant improvement.

Outbreaks of measles, mumps, pertussis (whooping cough), and other vaccine-preventable diseases still occur in the United States.

Vaccines help contain the spread of diseases and reduce morbidity and mortality.

Immunization is considered 1 of the 10 greatest public health achievements of the 20th century.

Among the many treatments for diseases, vaccines are the safest and most cost-effective form of preventive medicine in the United States.